Targeting CD8+ T-cell tolerance for cancer immunotherapy

Stephanie R Jackson ¹, Jinyun Yuan , Ryan M Teague

Affiliations

¹ Saint Louis University School of Medicine, Department of Molecular Microbiology & Immunology, 1100 South Grand Blvd, St Louis, MO 63104, USA.

PMID: 25290416
144 References
24 citations

Abstract

In the final issue of Science in 2013, the American Association of Science recognized progress in the field of cancer immunotherapy as the 'Breakthrough of the Year.' The achievements were actually twofold, owing to the early success of genetically engineered chimeric antigen receptors (CAR) and to the mounting clinical triumphs achieved with checkpoint blockade antibodies. While fundamentally very different, the common thread of these independent strategies is the ability to prevent or overcome mechanisms of CD8(+) T-cell tolerance for improved tumor immunity. Here we discuss how circumventing T-cell tolerance has provided experimental insights that have guided the field of clinical cancer immunotherapy to a place where real breakthroughs can finally be claimed.

Keywords: CD8+ T-cell checkpoint blockade; adoptive cell transfer; cancer immunotherapy; cancer vaccine; chimeric antigen receptor; lymphodepletion; tolerance.

Other Links

Free PMC article
Full text on Immunotherapy

References
Cited By

References
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. F Stephen Hodi, Marcus Butler, +17 authors, Glenn Dranoff. less Proc Natl Acad Sci U S A, 2008 Feb 22; 105(8). PMID: 18287062 Free PMC article. Highly Cited.
Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. L Chen, S Ashe, +5 authors, P S Linsley. less Cell, 1992 Dec 24; 71(7). PMID: 1335364 Highly Cited.
Restoring function in exhausted CD8 T cells during chronic viral infection. Daniel L Barber, E John Wherry, +5 authors, Rafi Ahmed. less Nature, 2005 Dec 31; 439(7077). PMID: 16382236 Highly Cited.
Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}. Mark P Rubinstein, Marek Kovar, +4 authors, Jonathan Sprent. less Proc Natl Acad Sci U S A, 2006 Jun 08; 103(24). PMID: 16757567 Free PMC article. Highly Cited.
In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB). De-Gang Song, Qunrui Ye, +7 authors, Daniel J Powell. less Cancer Res, 2011 May 07; 71(13). PMID: 21546571 Free PMC article. Highly Cited.
IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. Ilaria Peluso, Massimo Claudio Fantini, +5 authors, Giovanni Monteleone. less J Immunol, 2007 Jan 05; 178(2). PMID: 17202333
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. Luca Gattinoni, Steven E Finkelstein, +10 authors, Nicholas P Restifo. less J Exp Med, 2005 Oct 06; 202(7). PMID: 16203864 Free PMC article. Highly Cited.
Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. R J North. J Exp Med, 1982 Apr 01; 155(4). PMID: 6460831 Free PMC article. Highly Cited.
Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma. Antoni Ribas, Begoña Comin-Anduix, +15 authors, Jesus Gomez-Navarro. less Clin Cancer Res, 2009 Oct 01; 15(19). PMID: 19789309 Free PMC article.
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. Ganesh Suntharalingam, Meghan R Perry, +4 authors, Nicki Panoskaltsis. less N Engl J Med, 2006 Aug 16; 355(10). PMID: 16908486 Highly Cited.
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Mark E Dudley, John R Wunderlich, +16 authors, Steven A Rosenberg. less Science, 2002 Sep 21; 298(5594). PMID: 12242449 Free PMC article. Highly Cited.
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. Mark E Dudley, John R Wunderlich, +18 authors, Steven A Rosenberg. less J Clin Oncol, 2005 Apr 01; 23(10). PMID: 15800326 Free PMC article. Highly Cited.
A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemia. Richard R Furman, Andres Forero-Torres, Andrei Shustov, Jonathan G Drachman. Leuk Lymphoma, 2009 Dec 30; 51(2). PMID: 20038235
Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Catherine A Sabatos, Sumone Chakravarti, +7 authors, Vijay K Kuchroo. less Nat Immunol, 2003 Oct 14; 4(11). PMID: 14556006 Highly Cited.
Clinical perspectives on targeting of myeloid derived suppressor cells in the treatment of cancer. Yana G Najjar, James H Finke. Front Oncol, 2013 Mar 20; 3. PMID: 23508517 Free PMC article.
Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphoma. Lihua E Budde, Carolina Berger, +9 authors, Oliver W Press. less PLoS One, 2013 Dec 21; 8(12). PMID: 24358223 Free PMC article. Highly Cited.
Oligodendrocytes enforce immune tolerance of the uninfected brain by purging the peripheral repertoire of autoreactive CD8+ T cells. Shin-Young Na, Andreas Hermann, +3 authors, Thomas Hünig. less Immunity, 2012 Jun 12; 37(1). PMID: 22683122
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. Julie R Brahmer, Scott S Tykodi, +23 authors, Jon M Wigginton. less N Engl J Med, 2012 Jun 05; 366(26). PMID: 22658128 Free PMC article. Highly Cited.
Dendritic cells and the control of immunity. J Banchereau, R M Steinman. Nature, 1998 Apr 01; 392(6673). PMID: 9521319 Highly Cited. Review.
Cancer immunotherapy via dendritic cells. Karolina Palucka, Jacques Banchereau. Nat Rev Cancer, 2012 Mar 23; 12(4). PMID: 22437871 Free PMC article. Highly Cited. Review.
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. Paul F Robbins, Richard A Morgan, +18 authors, Steven A Rosenberg. less J Clin Oncol, 2011 Feb 02; 29(7). PMID: 21282551 Free PMC article. Highly Cited.
Improved survival with ipilimumab in patients with metastatic melanoma. F Stephen Hodi, Steven J O'Day, +26 authors, Walter J Urba. less N Engl J Med, 2010 Jun 08; 363(8). PMID: 20525992 Free PMC article. Highly Cited.
CAR T cells: driving the road from the laboratory to the clinic. Eleanor J Cheadle, Hannah Gornall, +3 authors, David E Gilham. less Immunol Rev, 2013 Dec 18; 257(1). PMID: 24329792 Review.
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. L Diehl, A T den Boer, +5 authors, R E Toes. less Nat Med, 1999 Jul 08; 5(7). PMID: 10395322 Highly Cited.
Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Thomas R Malek, Iris Castro. Immunity, 2010 Aug 25; 33(2). PMID: 20732639 Free PMC article. Highly Cited. Review.
CD40 ligation reverses T cell tolerance in acute myeloid leukemia. Long Zhang, Xiufen Chen, +4 authors, Justin Kline. less J Clin Invest, 2013 Apr 27; 123(5). PMID: 23619361 Free PMC article.
A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma. Mohamad Hussein, James R Berenson, +6 authors, Nancy Whiting. less Haematologica, 2010 Feb 06; 95(5). PMID: 20133895 Free PMC article.
First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meeting. Andrea Molckovsky, Lillian L Siu. J Hematol Oncol, 2008 Oct 31; 1. PMID: 18959794 Free PMC article.
The promise and potential pitfalls of chimeric antigen receptors. Michel Sadelain, Renier Brentjens, Isabelle Rivière. Curr Opin Immunol, 2009 Mar 31; 21(2). PMID: 19327974 Free PMC article. Highly Cited. Review.
Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2. T J Eberlein, M Rosenstein, S A Rosenberg. J Exp Med, 1982 Aug 01; 156(2). PMID: 6980254 Free PMC article. Highly Cited.
OX40 costimulation turns off Foxp3+ Tregs. Minh Diem Vu, Xiang Xiao, +6 authors, Xian Chang Li. less Blood, 2007 Jun 19; 110(7). PMID: 17575071 Free PMC article. Highly Cited.
Peripheral tolerance of CD8 T lymphocytes. William L Redmond, Linda A Sherman. Immunity, 2005 Mar 23; 22(3). PMID: 15780985 Review.
Adoptive immunotherapy for cancer: harnessing the T cell response. Nicholas P Restifo, Mark E Dudley, Steven A Rosenberg. Nat Rev Immunol, 2012 Mar 23; 12(4). PMID: 22437939 Free PMC article. Highly Cited. Review.
Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes--a molecule related to nerve growth factor receptor. S Mallett, S Fossum, A N Barclay. EMBO J, 1990 Apr 01; 9(4). PMID: 2157591 Free PMC article. Highly Cited.
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. David Saadoun, Michelle Rosenzwajg, +6 authors, David Klatzmann. less N Engl J Med, 2011 Dec 02; 365(22). PMID: 22129253 Highly Cited.
II. Contribution to the Knowledge of Sarcoma. W B Coley. Ann Surg, 1891 Sep 01; 14(3). PMID: 17859590 Free PMC article. Highly Cited.
Role of LAG-3 in regulatory T cells. Ching-Tai Huang, Creg J Workman, +11 authors, Dario A A Vignali. less Immunity, 2004 Oct 16; 21(4). PMID: 15485628 Highly Cited.
Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21. Louise E Clough, Chun Jing Wang, +4 authors, Lucy S K Walker. less J Immunol, 2008 Apr 09; 180(8). PMID: 18390721
Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients. Joannes F M Jacobs, Cornelis J A Punt, +8 authors, Gosse J Adema. less Clin Cancer Res, 2010 Aug 26; 16(20). PMID: 20736326
Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Steven A Rosenberg, Nicholas P Restifo, +2 authors, James C Yang, Richard A Morgan, Mark E Dudley. less Nat Rev Cancer, 2008 Mar 21; 8(4). PMID: 18354418 Free PMC article. Highly Cited. Review.
Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation. Nikolaos Patsoukis, Julia Brown, +3 authors, Victoria Petkova, Fang Liu, Lequn Li, Vassiliki A Boussiotis. less Sci Signal, 2012 Jun 29; 5(230). PMID: 22740686 Free PMC article. Highly Cited.
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. Suzanne L Topalian, F Stephen Hodi, +27 authors, Mario Sznol. less N Engl J Med, 2012 Jun 05; 366(26). PMID: 22658127 Free PMC article. Highly Cited.
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Michael A Curran, Welby Montalvo, Hideo Yagita, James P Allison. Proc Natl Acad Sci U S A, 2010 Feb 18; 107(9). PMID: 20160101 Free PMC article. Highly Cited.
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. Jens Dannull, Zhen Su, +8 authors, Johannes Vieweg. less J Clin Invest, 2005 Nov 26; 115(12). PMID: 16308572 Free PMC article. Highly Cited.
Phase I trial of ALT-801, an interleukin-2/T-cell receptor fusion protein targeting p53 (aa264-272)/HLA-A*0201 complex, in patients with advanced malignancies. Mayer N Fishman, John A Thompson, +8 authors, Hing C Wong. less Clin Cancer Res, 2011 Oct 14; 17(24). PMID: 21994418 Free PMC article.
A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma. William Bensinger, Richard T Maziarz, +8 authors, Edward A Stadtmauer. less Br J Haematol, 2012 Aug 07; 159(1). PMID: 22861192
IL-21 mediated Foxp3 suppression leads to enhanced generation of antigen-specific CD8+ cytotoxic T lymphocytes. Yongqing Li, Cassian Yee. Blood, 2007 Oct 09; 111(1). PMID: 17921346 Free PMC article.
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Jason D Fontenot, Marc A Gavin, Alexander Y Rudensky. Nat Immunol, 2003 Mar 04; 4(4). PMID: 12612578 Highly Cited.
Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Richard A Morgan, James C Yang, +3 authors, Steven A Rosenberg. less Mol Ther, 2010 Feb 25; 18(4). PMID: 20179677 Free PMC article. Highly Cited.
Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant state. Andrea Schietinger, Jeffrey J Delrow, +2 authors, Ryan S Basom, Joseph N Blattman, Philip D Greenberg. less Science, 2012 Jan 24; 335(6069). PMID: 22267581 Free PMC article. Highly Cited.
Systemic administration of interleukin-2 in humans. M T Lotze, R J Robb, +2 authors, S O Sharrow, L W Frana, S A Rosenberg. less J Biol Response Mod, 1984 Oct 01; 3(5). PMID: 6334135
The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming. Jacques Banchereau, LuAnn Thompson-Snipes, +6 authors, Eynav Klechevsky. less Blood, 2012 Apr 27; 119(24). PMID: 22535664 Free PMC article.
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Thomas A Waldmann. Nat Rev Immunol, 2006 Jul 27; 6(8). PMID: 16868550 Highly Cited. Review.
Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. B K Cho, V P Rao, +2 authors, Q Ge, H N Eisen, J Chen. less J Exp Med, 2000 Aug 22; 192(4). PMID: 10952724 Free PMC article. Highly Cited.
Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells. Andrew J Rech, Robert H Vonderheide. Ann N Y Acad Sci, 2009 Sep 23; 1174. PMID: 19769742 Highly Cited. Review.
Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. P Waterhouse, J M Penninger, +6 authors, T W Mak. less Science, 1995 Nov 10; 270(5238). PMID: 7481803 Highly Cited.
Mechanism of T cell tolerance induced by myeloid-derived suppressor cells. Srinivas Nagaraj, Adam G Schrum, +2 authors, Hyun-Il Cho, Esteban Celis, Dmitry I Gabrilovich. less J Immunol, 2010 Feb 10; 184(6). PMID: 20142361 Free PMC article. Highly Cited.
In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. Laura C Bonifaz, David P Bonnyay, +7 authors, Ralph M Steinman. less J Exp Med, 2004 Mar 17; 199(6). PMID: 15024047 Free PMC article. Highly Cited.
Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor. W R Godfrey, F F Fagnoni, +2 authors, M A Harara, D Buck, E G Engleman. less J Exp Med, 1994 Aug 01; 180(2). PMID: 7913952 Free PMC article.
Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. I Gramaglia, A D Weinberg, M Lemon, M Croft. J Immunol, 1998 Dec 23; 161(12). PMID: 9862675 Highly Cited.
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. C Marcela Diaz-Montero, Mohamed Labib Salem, +3 authors, Alberto J Montero. less Cancer Immunol Immunother, 2008 May 01; 58(1). PMID: 18446337 Free PMC article. Highly Cited.
Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. L A Schubert, E Jeffery, +2 authors, Y Zhang, F Ramsdell, S F Ziegler. less J Biol Chem, 2001 Aug 03; 276(40). PMID: 11483607 Highly Cited.
Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. S Read, V Malmström, F Powrie. J Exp Med, 2000 Jul 19; 192(2). PMID: 10899916 Free PMC article. Highly Cited.
Durable adoptive immunotherapy for leukemia produced by manipulation of multiple regulatory pathways of CD8+ T-cell tolerance. Melissa M Berrien-Elliott, Stephanie R Jackson, +6 authors, Ryan M Teague. less Cancer Res, 2012 Nov 29; 73(2). PMID: 23188506 Free PMC article.
Potential uses of interleukin 2 in cancer therapy. M A Cheever, J A Thompson, D J Peace, P D Greenberg. Immunobiology, 1986 Sep 01; 172(3-5). PMID: 3492434
PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model. Long Zhang, Thomas F Gajewski, Justin Kline. Blood, 2009 May 07; 114(8). PMID: 19417208 Free PMC article. Highly Cited.
Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function. Jessica Ann Hernandez-Chacon, Yufeng Li, +5 authors, Laszlo G Radvanyi. less J Immunother, 2011 Mar 11; 34(3). PMID: 21389874 Free PMC article.
Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors. Ryan M Teague, Blythe D Sather, +8 authors, Philip D Greenberg. less Nat Med, 2006 Feb 14; 12(3). PMID: 16474399
Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'. Aron M Levin, Darren L Bates, +11 authors, K Christopher Garcia. less Nature, 2012 Mar 27; 484(7395). PMID: 22446627 Free PMC article. Highly Cited.
Development of a Listeria monocytogenes based vaccine against prostate cancer. Vafa Shahabi, Mariela Reyes-Reyes, +3 authors, Paulo Maciag. less Cancer Immunol Immunother, 2008 Feb 15; 57(9). PMID: 18273616
Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning. Hollie J Pegram, James C Lee, +4 authors, Renier J Brentjens. less Blood, 2012 Feb 23; 119(18). PMID: 22354001 Free PMC article. Highly Cited.
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Tyler J Curiel, George Coukos, +18 authors, Weiping Zou. less Nat Med, 2004 Aug 24; 10(9). PMID: 15322536 Highly Cited.
High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findings. M T Lotze, A E Chang, +3 authors, C A Seipp, C Simpson, J T Vetto, S A Rosenberg. less JAMA, 1986 Dec 12; 256(22). PMID: 3491225 Highly Cited.
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. P P Lee, C Yee, +9 authors, M M Davis. less Nat Med, 1999 Jun 17; 5(6). PMID: 10371507 Highly Cited.
Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody. Robert H Vonderheide, Keith T Flaherty, +12 authors, Scott J Antonia. less J Clin Oncol, 2007 Mar 01; 25(7). PMID: 17327609 Highly Cited.
Cytosolic entry controls CD8+-T-cell potency during bacterial infection. Keith S Bahjat, Weiqun Liu, +4 authors, Dirk G Brockstedt. less Infect Immun, 2006 Sep 07; 74(11). PMID: 16954391 Free PMC article.
CAR T cells transform to trucks: chimeric antigen receptor-redirected T cells engineered to deliver inducible IL-12 modulate the tumour stroma to combat cancer. Markus Chmielewski, Hinrich Abken. Cancer Immunol Immunother, 2012 Jan 26; 61(8). PMID: 22274776 Review.
Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer. Nicholas C Souders, Duane A Sewell, +4 authors, Yvonne Paterson. less Cancer Immun, 2007 Feb 07; 7. PMID: 17279610 Free PMC article.
A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction. Dung T Le, Dirk G Brockstedt, +19 authors, Daniel A Laheru. less Clin Cancer Res, 2011 Dec 08; 18(3). PMID: 22147941 Free PMC article. Highly Cited.
Basic principles of tumor-associated regulatory T cell biology. Peter A Savage, Sven Malchow, Daniel S Leventhal. Trends Immunol, 2012 Sep 25; 34(1). PMID: 22999714 Free PMC article. Review.
New insights into the regulation of T cells by gamma(c) family cytokines. Yrina Rochman, Rosanne Spolski, Warren J Leonard. Nat Rev Immunol, 2009 Jun 23; 9(7). PMID: 19543225 Free PMC article. Highly Cited. Review.
Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Onur Boyman, Marek Kovar, +2 authors, Mark P Rubinstein, Charles D Surh, Jonathan Sprent. less Science, 2006 Feb 18; 311(5769). PMID: 16484453 Highly Cited.
Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers. J T Vetto, S Lum, +4 authors, A Weinberg. less Am J Surg, 1997 Oct 27; 174(3). PMID: 9324133
Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia. John C Byrd, Thomas J Kipps, +8 authors, Susan O'Brien. less Leuk Lymphoma, 2012 Apr 06; 53(11). PMID: 22475052 Free PMC article.
Raising the bar: the curative potential of human cancer immunotherapy. Steven A Rosenberg. Sci Transl Med, 2012 Mar 31; 4(127). PMID: 22461638 Free PMC article. Highly Cited. Review.
T cell receptor gene therapy for cancer. Thomas M Schmitt, Gunnar B Ragnarsson, Philip D Greenberg. Hum Gene Ther, 2009 Aug 26; 20(11). PMID: 19702439 Free PMC article. Review.
CTLA-4: new insights into its biological function and use in tumor immunotherapy. Jackson G Egen, Michael S Kuhns, James P Allison. Nat Immunol, 2002 Jun 28; 3(7). PMID: 12087419 Highly Cited. Review.
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Haidong Dong, Scott E Strome, +10 authors, Lieping Chen. less Nat Med, 2002 Jul 02; 8(8). PMID: 12091876 Highly Cited.
IL-15:IL-15 receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization. Kai-ping Han, Xiaoyun Zhu, +9 authors, Hing C Wong. less Cytokine, 2011 Oct 25; 56(3). PMID: 22019703 Free PMC article.
Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. A W Goldrath, L Y Bogatzki, M J Bevan. J Exp Med, 2000 Aug 22; 192(4). PMID: 10952725 Free PMC article. Highly Cited.
Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J Hernandez, S Aung, W L Redmond, L A Sherman. J Exp Med, 2001 Sep 19; 194(6). PMID: 11560988 Free PMC article.
The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix. Paulo Cesar Maciag, Sinisa Radulovic, John Rothman. Vaccine, 2009 Apr 25; 27(30). PMID: 19389451 Highly Cited.
Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40. E M Sotomayor, I Borrello, +6 authors, H I Levitsky. less Nat Med, 1999 Jul 08; 5(7). PMID: 10395323 Highly Cited.
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Steven A Rosenberg, James C Yang, +12 authors, Mark E Dudley. less Clin Cancer Res, 2011 Apr 19; 17(13). PMID: 21498393 Free PMC article. Highly Cited.
Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells: case report of an unforeseen adverse event in a phase I clinical trial. Renier Brentjens, Raymond Yeh, +2 authors, Yvette Bernal, Isabelle Riviere, Michel Sadelain. less Mol Ther, 2010 Apr 02; 18(4). PMID: 20357779 Free PMC article. Highly Cited.
OX40 is a potent immune-stimulating target in late-stage cancer patients. Brendan D Curti, Magdalena Kovacsovics-Bankowski, +20 authors, Andrew D Weinberg. less Cancer Res, 2013 Nov 02; 73(24). PMID: 24177180 Free PMC article. Highly Cited.
In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2. M T Lotze, Y L Matory, +5 authors, S A Rosenberg. less J Immunol, 1985 Oct 01; 135(4). PMID: 2993418 Highly Cited.
4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. W W Shuford, K Klussman, +11 authors, R S Mittler. less J Exp Med, 1997 Jul 07; 186(1). PMID: 9206996 Free PMC article. Highly Cited.
Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. I Melero, W W Shuford, +5 authors, L Chen. less Nat Med, 1997 Jun 01; 3(6). PMID: 9176498 Highly Cited.
Nivolumab plus ipilimumab in advanced melanoma. Jedd D Wolchok, Harriet Kluger, +21 authors, Mario Sznol. less N Engl J Med, 2013 Jun 04; 369(2). PMID: 23724867 Free PMC article. Highly Cited.
Enhanced-affinity murine T-cell receptors for tumor/self-antigens can be safe in gene therapy despite surpassing the threshold for thymic selection. Thomas M Schmitt, David H Aggen, +4 authors, Philip D Greenberg. less Blood, 2013 May 16; 122(3). PMID: 23673862 Free PMC article.
Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myeloma. Wenxin Xu, Monica Jones, +10 authors, Hing C Wong. less Cancer Res, 2013 May 07; 73(10). PMID: 23644531 Free PMC article. Highly Cited.
Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. G R Gunn, A Zubair, +3 authors, C Peters, Z K Pan, T C Wu, Y Paterson. less J Immunol, 2001 Nov 21; 167(11). PMID: 11714814
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. Tyler R Simpson, Fubin Li, +11 authors, Sergio A Quezada. less J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981 Free PMC article. Highly Cited.
Harnessing human dendritic cell subsets for medicine. Hideki Ueno, Nathalie Schmitt, +8 authors, Karolina Palucka. less Immunol Rev, 2010 Mar 03; 234(1). PMID: 20193020 Free PMC article. Review.
Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells. Joseph F Grosso, Monica V Goldberg, +7 authors, Charles G Drake. less J Immunol, 2009 May 21; 182(11). PMID: 19454660 Free PMC article.
The blockade of immune checkpoints in cancer immunotherapy. Drew M Pardoll. Nat Rev Cancer, 2012 Mar 23; 12(4). PMID: 22437870 Free PMC article. Highly Cited. Review.
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. B Almand, J I Clark, +5 authors, D I Gabrilovich. less J Immunol, 2000 Dec 21; 166(1). PMID: 11123353 Highly Cited.
Management of immune-related adverse events and kinetics of response with ipilimumab. Jeffrey S Weber, Katharina C Kähler, Axel Hauschild. J Clin Oncol, 2012 May 23; 30(21). PMID: 22614989 Highly Cited. Review.
Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma. Markus Chmielewski, Andreas A Hombach, Hinrich Abken. Immunol Rev, 2013 Dec 18; 257(1). PMID: 24329791 Review.
Sipuleucel-T immunotherapy for castration-resistant prostate cancer. Philip W Kantoff, Celestia S Higano, +11 authors, IMPACT Study Investigators. less N Engl J Med, 2010 Sep 08; 363(5). PMID: 20818862 Highly Cited.
Immune evasion in acute myeloid leukemia: current concepts and future directions. Ryan M Teague, Justin Kline. J Immunother Cancer, 2013 Dec 20; 1(13). PMID: 24353898 Free PMC article.
Cancer regression in patients after transfer of genetically engineered lymphocytes. Richard A Morgan, Mark E Dudley, +13 authors, Steven A Rosenberg. less Science, 2006 Sep 02; 314(5796). PMID: 16946036 Free PMC article. Highly Cited.
Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. Richard A Morgan, Nachimuthu Chinnasamy, +28 authors, Steven A Rosenberg. less J Immunother, 2013 Feb 05; 36(2). PMID: 23377668 Free PMC article. Highly Cited.
Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. Ryan A Wilcox, Dallas B Flies, +6 authors, Lieping Chen. less J Clin Invest, 2002 Mar 06; 109(5). PMID: 11877473 Free PMC article.
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Arlene H Sharpe, E John Wherry, Rafi Ahmed, Gordon J Freeman. Nat Immunol, 2007 Feb 17; 8(3). PMID: 17304234 Highly Cited. Review.
IL-12 release by engineered T cells expressing chimeric antigen receptors can effectively Muster an antigen-independent macrophage response on tumor cells that have shut down tumor antigen expression. Markus Chmielewski, Caroline Kopecky, Andreas A Hombach, Hinrich Abken. Cancer Res, 2011 Jul 12; 71(17). PMID: 21742772 Highly Cited.
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. Christian S Hinrichs, Rosanne Spolski, +7 authors, Nicholas P Restifo. less Blood, 2008 Feb 16; 111(11). PMID: 18276844 Free PMC article. Highly Cited.
Selective in vitro growth of T lymphocytes from normal human bone marrows. D A Morgan, F W Ruscetti, R Gallo. Science, 1976 Sep 10; 193(4257). PMID: 181845 Highly Cited.
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma. Gerald P Linette, Edward A Stadtmauer, +20 authors, Carl H June. less Blood, 2013 Jun 19; 122(6). PMID: 23770775 Free PMC article. Highly Cited.
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. Kaori Sakuishi, Lionel Apetoh, +3 authors, Ana C Anderson. less J Exp Med, 2010 Sep 08; 207(10). PMID: 20819927 Free PMC article. Highly Cited.
CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help. R R French, H T Chan, A L Tutt, M J Glennie. Nat Med, 1999 May 06; 5(5). PMID: 10229232 Highly Cited.
Re-adapting T cells for cancer therapy: from mouse models to clinical trials. Ingunn M Stromnes, Thomas M Schmitt, +2 authors, Aude G Chapuis, Sunil R Hingorani, Philip D Greenberg. less Immunol Rev, 2013 Dec 18; 257(1). PMID: 24329795 Free PMC article. Review.
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. Rong Zeng, Rosanne Spolski, +9 authors, Warren J Leonard. less J Exp Med, 2005 Jan 05; 201(1). PMID: 15630141 Free PMC article. Highly Cited.
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. D Hawiger, K Inaba, +6 authors, M C Nussenzweig. less J Exp Med, 2001 Sep 19; 194(6). PMID: 11560993 Free PMC article. Highly Cited.
Interleukin-21: basic biology and implications for cancer and autoimmunity. Rosanne Spolski, Warren J Leonard. Annu Rev Immunol, 2007 Oct 24; 26. PMID: 17953510 Highly Cited. Review.
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Omar S Qureshi, Yong Zheng, +12 authors, David M Sansom. less Science, 2011 Apr 09; 332(6029). PMID: 21474713 Free PMC article. Highly Cited.
Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. T Takahashi, T Tagami, +5 authors, S Sakaguchi. less J Exp Med, 2000 Jul 19; 192(2). PMID: 10899917 Free PMC article. Highly Cited.
Studies on the immunological response to foreign tumor transplants in the mouse. I. The role of lymph node cells in conferring immunity by adoptive transfer. N A MITCHISON. J Exp Med, 1955 Aug 01; 102(2). PMID: 13242741 Free PMC article. Highly Cited.
OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor. Michael J Gough, Carl E Ruby, +3 authors, Andrew D Weinberg. less Cancer Res, 2008 Jul 03; 68(13). PMID: 18593921
Mitigating the toxic effects of anticancer immunotherapy. Tara C Gangadhar, Robert H Vonderheide. Nat Rev Clin Oncol, 2014 Jan 22; 11(2). PMID: 24445516 Highly Cited. Review.
Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Wei Liao, Jian-Xin Lin, Warren J Leonard. Immunity, 2013 Jan 29; 38(1). PMID: 23352221 Free PMC article. Highly Cited. Review.
Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. Stephan A Grupp, Michael Kalos, +10 authors, Carl H June. less N Engl J Med, 2013 Mar 27; 368(16). PMID: 23527958 Free PMC article. Highly Cited.
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity. Suzanne Ostrand-Rosenberg. Cancer Immunol Immunother, 2010 Apr 24; 59(10). PMID: 20414655 Free PMC article. Highly Cited. Review.
Molecular basis of T cell inactivation by CTLA-4. K M Lee, E Chuang, +7 authors, J A Bluestone. less Science, 1998 Dec 18; 282(5397). PMID: 9856951 Highly Cited.
OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. P R Rogers, J Song, +2 authors, I Gramaglia, N Killeen, M Croft. less Immunity, 2001 Sep 25; 15(3). PMID: 11567634 Highly Cited.
Combination checkpoint blockade--taking melanoma immunotherapy to the next level. James L Riley. N Engl J Med, 2013 Jun 04; 369(2). PMID: 23724866
Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Alberto Sánchez-Fueyo, Jane Tian, +10 authors, Terry B Strom. less Nat Immunol, 2003 Oct 14; 4(11). PMID: 14556005 Highly Cited.
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. Omid Hamid, Caroline Robert, +23 authors, Antoni Ribas. less N Engl J Med, 2013 Jun 04; 369(2). PMID: 23724846 Free PMC article. Highly Cited.
TNF/TNFR family members in costimulation of T cell responses. Tania H Watts. Annu Rev Immunol, 2005 Mar 18; 23. PMID: 15771565 Highly Cited. Review.
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. S A Rosenberg, J C Yang, +13 authors, D E White. less Nat Med, 1998 Mar 21; 4(3). PMID: 9500606 Free PMC article. Highly Cited.
The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities. J P Siegel, M Sharon, P L Smith, W J Leonard. Science, 1987 Oct 02; 238(4823). PMID: 3116668 Highly Cited.
Induction of cytotoxicity in resting human T lymphocytes bound to tumor cells by antibody heteroconjugates. G Jung, J A Ledbetter, H J Müller-Eberhard. Proc Natl Acad Sci U S A, 1987 Jul 01; 84(13). PMID: 3110771 Free PMC article.
CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases. Christine Guntermann, Denis R Alexander. J Immunol, 2002 Apr 24; 168(9). PMID: 11970985

Citedby
Neuropilin-1 expression is induced on tolerant self-reactive CD8+ T cells but is dispensable for the tolerant phenotype. Stephanie R Jackson, Melissa Berrien-Elliott, +2 authors, Jinyun Yuan, Eddy C Hsueh, Ryan M Teague. less PLoS One, 2014 Oct 25; 9(10). PMID: 25343644 Free PMC article.
Checkpoint blockade immunotherapy relies on T-bet but not Eomes to induce effector function in tumor-infiltrating CD8+ T cells. Melissa M Berrien-Elliott, Jinyun Yuan, +4 authors, Ryan M Teague. less Cancer Immunol Res, 2014 Dec 18; 3(2). PMID: 25516478 Free PMC article.
Immune based therapy for melanoma. Robert Ancuceanu, Monica Neagu. Indian J Med Res, 2016 Apr 29; 143(2). PMID: 27121512 Free PMC article. Review.
Rescue of Tolerant CD8+ T Cells during Cancer Immunotherapy with IL2:Antibody Complexes. Lauryn E Klevorn, Melissa M Berrien-Elliott, +4 authors, Ryan M Teague. less Cancer Immunol Res, 2016 Nov 03; 4(12). PMID: 27803062 Free PMC article.
Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy. Preeti Kanikarla-Marie, Michael Lam, +3 authors, David G Menter. less Front Oncol, 2018 May 08; 8. PMID: 29732316 Free PMC article. Review.
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells. Gray Kueberuwa, Weiming Zheng, +2 authors, Milena Kalaitsidou, David E Gilham, Robert E Hawkins. less J Vis Exp, 2018 Nov 06; (140). PMID: 30394400 Free PMC article.
Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma. Douglas J Hartman, Fahad Ahmad, +2 authors, Robert L Ferris, David L Rimm, Liron Pantanowitz. less Oral Oncol, 2018 Nov 10; 86. PMID: 30409313 Free PMC article.
Immunotherapy in Ovarian Cancer. Weimin Wang, Janice Rebecca Liu, Weiping Zou. Surg Oncol Clin N Am, 2019 May 14; 28(3). PMID: 31079799 Free PMC article. Review.
TCR Retrogenic Mice as a Model To Map Self-Tolerance Mechanisms to the Cancer Mucosa Antigen GUCY2C. Tara S Abraham, John C Flickinger, Scott A Waldman, Adam E Snook. J Immunol, 2019 Jan 16; 202(4). PMID: 30642983 Free PMC article.
Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells. Jean-François Rossi, Patrice Céballos, Zhao-Yang Lu. Cancer Commun (Lond), 2019 Jun 16; 39(1). PMID: 31200766 Free PMC article. Review.
Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy. Carina Hage, Sabine Hoves, +8 authors, Thomas Pöschinger. less PLoS One, 2019 Jul 11; 14(7). PMID: 31291357 Free PMC article.
What is the potential use of platelet-rich-plasma (PRP) in cancer treatment? A mini review. Angela C M Luzo, Wagner J Fávaro, Amedea B Seabra, Nelson Durán. Heliyon, 2020 Apr 08; 6(3). PMID: 32258495 Free PMC article. Review.
Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy. Rama Soundararajan, Jared J Fradette, +18 authors, Sendurai A Mani. less Cancers (Basel), 2019 May 30; 11(5). PMID: 31137625 Free PMC article. Review.
Engineering bionic T cells: signal 1, signal 2, signal 3, reprogramming and the removal of inhibitory mechanisms. Iñaki Etxeberria, Irene Olivera, +4 authors, Ignacio Melero. less Cell Mol Immunol, 2020 May 21; 17(6). PMID: 32433539 Free PMC article. Review.
Stimuli-Responsive Biomaterials for Vaccines and Immunotherapeutic Applications. Noah Pacifici, Amir Bolandparvaz, Jamal S Lewis. Adv Ther (Weinh), 2020 Aug 25;. PMID: 32838028 Free PMC article.
Recombinant AAV-CEA Tumor Vaccine in Combination with an Immune Adjuvant Breaks Tolerance and Provides Protective Immunity. Jonathan A Hensel, Vinayak Khattar, Reading Ashton, Selvarangan Ponnazhagan. Mol Ther Oncolytics, 2019 Jan 23; 12. PMID: 30666318 Free PMC article.
Boosting the Immune Response with the Combination of Electrochemotherapy and Immunotherapy: A New Weapon for Squamous Cell Carcinoma of the Head and Neck? Francesco Longo, Francesco Perri, +8 authors, Raffaele Solla. less Cancers (Basel), 2020 Oct 02; 12(10). PMID: 32998297 Free PMC article.
The suppressive effect of co-inhibiting PD-1 and CTLA-4 expression on H22 hepatomas in mice. Leilei Liang, Keli Ge, Fengying Zhang, Yinlin Ge. Cell Mol Biol Lett, 2018 Dec 20; 23. PMID: 30564277 Free PMC article.
Defining muscle-invasive bladder cancer immunotypes by introducing tumor mutation burden, CD8+ T cells, and molecular subtypes. Zihao Chen, Guojun Liu, +5 authors, Zhifeng Wang. less Hereditas, 2021 Jan 04; 158(1). PMID: 33388091 Free PMC article.
Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigen. Zoila A Lopez-Bujanda, Matthew G Chaimowitz, +3 authors, Charles G Drake. less Oncoimmunology, 2021 Jan 19; 9(1). PMID: 33457094 Free PMC article.
A Palette of Cytokines to Measure Anti-Tumor Efficacy of T Cell-Based Therapeutics. Prathyaya Ramesh, Rohan Shivde, +2 authors, Dinesh Jaishankar, Diana Saleiro, I Caroline Le Poole. less Cancers (Basel), 2021 Mar 07; 13(4). PMID: 33669271 Free PMC article. Review.
The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy. Miles Piper, Adam C Mueller, Sana D Karam. Mol Carcinog, 2020 May 05; 59(7). PMID: 32363633 Free PMC article. Review.
Robust Prediction of Immune Checkpoint Inhibition Therapy for Non-Small Cell Lung Cancer. Jiehan Jiang, Zheng Jin, +9 authors, Kui Xiao. less Front Immunol, 2021 May 01; 12. PMID: 33927719 Free PMC article.
Cisplatin remodels the tumor immune microenvironment via the transcription factor EB in ovarian cancer. Wei Liu, Yanqiu Wang, +4 authors, Yonghui Zou. less Cell Death Discov, 2021 Jun 07; 7(1). PMID: 34091590 Free PMC article.

BioKDE: Biomedical Knowledge Discovery Engine

Abstract

Other Links